Abstract
ObjectiveThis study seeks to evaluate the clinical effectiveness and cost-effectiveness of FreeStyle Libre® versus traditional monitoring in patients with type 1 Diabetes Mellitus in the Health Area of Burgos (Spain). MethodA transversal ambispective descriptive study was carried out to compare costs and effectiveness between two forms of glycaemic control. The information was obtained from the computerized clinical history (Medora) and by referring to patients. An analysis of the monitoring material and clinical glycaemic control variables (HbA1c and symptomatic hypoglycaemia events, <70mg/dl) were carried out one year before and one year after the start of FreeStyle Libre®. ResultsWe included 23 patients with 1 of 35.4 (±15.1) years old (60.9% males). Monitoring by FreeStyle Libre® system has an average annual cost per patient four times higher than the traditional method. The HbA1c level was reduced by 5% (p=.024) and the rate of symptomatic hypoglycaemia decreased by 58.9% (p=.013). This determines an effectiveness in the Absolute Risk Reduction of .232 (23.2%) of hypoglycaemia and an incremental cost-effectiveness of €6194.71. ConclusionsThe FreeStyle Libre® system has a high clinical effectiveness associated with a high but potentially acceptable cost for glycaemia monitoring in Type 1 Diabetes Mellitus.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
